Skip to main content

BBVA vs Johnson & Johnson: Founders, CEOs and History

BBVA was founded in 1857 by Bilbao Board of Trade and is led by Onur Genç. Johnson & Johnson was founded in 1886 by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson and is led by Joaquin Duato.

Company facts

BBVA

Founded
1857
Headquarters
Madrid, Spain
Current CEO
Onur Genç
Employees
127,174

Johnson & Johnson

Founded
1886
Headquarters
New Brunswick, New Jersey
Current CEO
Joaquin Duato
Employees
140,800

Founders

BBVA

  • Bilbao Board of Trade

    No individual is recorded as the founder of BBVA's oldest institution. Banco de Bilbao was created in 1857 after the Bilbao Board of Trade, the body representing the port city's merchants, promoted a bank that could issue banknotes and discount commercial bill…

BBVA founders in full

Johnson & Johnson

  • Robert Wood Johnson

    Robert Wood Johnson (1845-1910) co-founded Johnson & Johnson in 1886 and served as its first president.

  • James Wood Johnson

    James Wood Johnson (1856-1932) co-founded J&J with his brothers in 1886. An engineer by trade, he designed the early manufacturing machinery that allowed the company to mass-produce sterile surgical dressings.

  • Edward Mead Johnson

    Edward Mead Johnson (1852-1934) co-founded J&J in 1886, bringing crucial sales and marketing expertise to the early business.

Johnson & Johnson founders in full

CEOs and their tenures

BBVA

  1. Pedro Luis Uriarte1999–2001

    Chief Executive Officer

    Chief executive and vice chairman of BBV from September 1994 and of the merged BBVA until he retired at the end of 2001.

    Source
  2. Francisco Gonzalez2000–2018

    Executive Chairman

    Chaired Argentaria before its 1999 merger with BBV and then BBVA until December 2018, 22 years at the head of the group in total. He drove the bank's technology rebuild and the 2007 purchase of Compass Bancshares in the United States.

    Source
  3. Jose Ignacio Goirigolzarri2001–2009

    Chief Executive Officer

    Chief executive of BBVA from 2001 to 2009, the period that covered the USD4.1 billion buyout of the rest of BBVA Bancomer in 2004 and the USD9.6 billion purchase of Compass Bancshares in 2007. He later chaired Bankia and CaixaBank.

    Source
  4. Angel Cano2009–2015

    Chief Executive Officer

    Appointed chief executive in September 2009, replacing Jose Ignacio Goirigolzarri.

    Source
  5. Carlos Torres Vila2015–2018

    Chief Executive Officer

    Chief executive from May 2015 until December 31, 2018, when he became executive chairman and Onur Genc took over as CEO. He had joined BBVA in 2008 to run strategy and corporate development and led digital banking from 2014.

    Source
  6. Onur Genc2018–present

    Chief Executive Officer

    Took over as CEO on December 31, 2018, the day Carlos Torres Vila became executive chairman.

    Source
BBVA CEO history in full

Johnson & Johnson

  1. Ralph Larsen1989–2002

    Former Chairman and Chief Executive Officer

    Larsen's acquisitions, including Neutrogena, Cordis, DePuy, and Centocor, broadened J&J into medical devices and biologics, laying groundwork for today's MedTech segment and immunology franchise.

    Source
  2. William Weldon2002–2012

    Former Chairman and Chief Executive Officer

    Weldon's later years were overshadowed by a wave of consumer product recalls, including Tylenol and Motrin, tied to manufacturing-quality problems.

    Source
  3. Alex Gorsky2012–2022

    Former Chairman and Chief Executive Officer

    Gorsky's tenure set up the 2023 Kenvue separation completed under his successor and saw J&J's single-dose COVID-19 vaccine authorized in 2021. He also oversaw the $30 billion Actelion acquisition in 2017 and the early years of talc litigation.

    Source
  4. Joaquin Duato2022–present

    Chairman and Chief Executive Officer

    Under Duato, J&J's sales reached $94.193 billion in FY2025 with $26.804 billion in net earnings, and the company guides to its first $100 billion year in 2026. He also launched the DePuy Synthes separation and the 2026 talc settlement proposal.

    Source
Johnson & Johnson CEO history in full

Timeline: BBVA and Johnson & Johnson side by side

  1. 1857BBVA

    Banco de Bilbao is created

    Bilbao's Board of Trade promotes the creation of Banco de Bilbao as a bank of issue and discount for the city's merchants. It is the oldest institution in BBVA's corporate line.

  2. 1886Johnson & Johnson

    Johnson & Johnson Founded

    Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson found the company in New Brunswick, New Jersey, with 14 employees, to mass-produce sterile surgical dressings after Robert was inspired by antiseptic pioneer Joseph Lister's 1885 warnings about i…

  3. 1901BBVA

    Banco de Vizcaya is founded

    Banco de Vizcaya is founded in Bilbao and grows alongside Banco de Bilbao as the second large Basque bank, financing regional industry.

  4. 1920Johnson & Johnson

    Band-Aid Brand Adhesive Bandages Introduced

    J&J introduces the first mass-produced adhesive bandage, sold under the Band-Aid brand starting in 1921; it becomes one of the most recognized consumer-health brands in the world before J&J later spins its consumer division out as Kenvue in 2023.

  5. 1943Johnson & Johnson

    Robert Wood Johnson II Writes 'Our Credo'

    Chairman Robert Wood Johnson II authors 'Our Credo,' a one-page statement ranking the company's responsibilities to customers, employees, communities, and shareholders in that order; it remains J&J's official governing philosophy and was later cited as the bas…

  6. 1944Johnson & Johnson

    J&J Goes Public

    Johnson & Johnson lists publicly, becoming an independent, market-traded company as it expands into a diversified healthcare business under Chairman Robert Wood Johnson II.

  7. 1982Johnson & Johnson

    Tylenol Cyanide Poisonings and Nationwide Recall

    After seven people in the Chicago area die from cyanide-laced Extra-Strength Tylenol capsules, J&J issues a nationwide recall of 31 million bottles within a week -- far beyond what investigators said was necessary -- citing Our Credo's customer-safety priority…

  8. 1988BBVA

    Banco de Bilbao and Banco de Vizcaya merge

    The two Basque rivals merge to form Banco Bilbao Vizcaya (BBV), one of the largest banks in Spain ahead of the European single market.

  9. 1999BBVA

    BBV merges with Argentaria to create BBVA

    BBV merges with Argentaria, the group Spain had assembled from state-owned lenders such as Banco Exterior, Banco Hipotecario and Caja Postal, forming Banco Bilbao Vizcaya Argentaria.

  10. 2000BBVA

    BBVA takes control of Bancomer in Mexico

    BBVA capitalizes Bancomer with USD1.4 billion and merges it with BBV-Probursa to create Grupo Financiero BBVA Bancomer, the largest bank in Mexico.

  11. 2004BBVA

    BBVA bids for the rest of BBVA Bancomer

    BBVA offers USD4.1 billion in cash for the roughly 41 percent of BBVA Bancomer held by minority investors, ending with about 99 percent of the Mexican group.

  12. 2007BBVA

    Compass Bancshares purchase builds a US franchise

    BBVA buys Compass Bancshares of Birmingham, Alabama for USD9.6 billion, creating a Sunbelt retail bank that later traded as BBVA Compass and BBVA USA.

  13. 2010BBVA

    BBVA agrees to buy 24.9 percent of Garanti

    BBVA agrees to pay ~$4.74 billion (EUR4.195 billion), about USD5.84 billion, for 24.9 percent of Turkiye Garanti Bankasi, funded with a rights issue of about $5.65 billion (EUR5 billion).

  14. 2012Johnson & Johnson

    Alex Gorsky Becomes CEO

    Gorsky succeeds William Weldon as CEO amid a period of manufacturing-quality recalls, and spends the next decade restoring J&J's operational reputation while expanding the pharmaceutical and MedTech businesses and developing a single-dose COVID-19 vaccine duri…

  15. 2014BBVA

    BBVA wins the auction for Catalunya Banc

    BBVA bids ~$1.34 billion (EUR1.187 billion) for Catalunya Banc, with 1.5 million customers and ~$71.2 billion (EUR63 billion) of assets, in the auction run by Spain's bank restructuring fund. The deal closed in 2015.

  16. 2018BBVA

    Onur Genc is named CEO

    BBVA's board designates Onur Genc as chief executive from December 31, 2018, the date Carlos Torres Vila replaces Francisco Gonzalez as executive chairman.

  17. 2019BBVA

    BBVA unifies its brand worldwide

    The group drops local names such as BBVA Bancomer, BBVA Francés, BBVA Continental and BBVA Compass and operates as BBVA in every market.

  18. 2021BBVA

    BBVA closes the transfer of BBVA USA to PNC

    BBVA completes the transfer of BBVA USA Bancshares to PNC Financial Services on June 1, 2021, receiving about USD11.5 billion, equivalent to ~$10.8 billion (EUR9.6 billion), in cash.

  19. 2022BBVA

    Tender offer lifts the Garanti stake to 85.97 percent

    A tender offer at 15 Turkish lira per share closes in May 2022 and raises BBVA's holding in Garanti BBVA to 85.97 percent.

  20. 2022Johnson & Johnson

    Joaquin Duato Becomes CEO

    Duato becomes CEO in January 2022, later adding the chairman title, and begins preparing the separation of J&J's consumer-health business from its medicine and device operations.

  21. 2023Johnson & Johnson

    Kenvue Separation

    J&J completes the spinoff of its consumer-health business (Band-Aid, Tylenol, Listerine, Neutrogena) as the standalone public company Kenvue, narrowing J&J around its higher-margin Innovative Medicine and MedTech segments.

  22. 2025BBVA

    The offer for Banco Sabadell lapses

    Shareholders representing 25.47 percent of Sabadell's voting rights accept BBVA's all-share offer, short of the minimum BBVA required, and the bid lapses on October 16, 2025.

  23. 2025BBVA

    Record net attributable profit of ~$11.9B (EUR10.511B)

    BBVA reports gross income of ~$41.7B (EUR36.931B) and net attributable profit of ~$11.9B (EUR10.511B) for 2025, with ROTE of 19.3 percent and an efficiency ratio of 38.8 percent.

  24. 2025Johnson & Johnson

    FY2025 Sales of $94.193B

    Johnson & Johnson reports $94.193 billion in sales and $26.804 billion in net earnings, split roughly 64% Innovative Medicine and 36% MedTech, both segments growing about 6% year over year.

  25. 2025Johnson & Johnson

    Orthopaedics Separation Announced

    In October 2025 J&J announced plans to separate its orthopaedics business as a standalone company operating as DePuy Synthes, targeting completion in 2027.

  26. 2026BBVA

    BBVA is ordered to stand trial in the Villarejo case

    Spain's National Court orders BBVA, former chairman Francisco Gonzalez and 14 other defendants to stand trial over work commissioned from former police commissioner Jose Manuel Villarejo between 2004 and 2016.

  27. 2026Johnson & Johnson

    Proposed Talc Resolution and Raised Guidance

    J&J raised 2026 sales guidance to about $101.1 billion after Q2 sales of $25.31 billion, and on July 27, 2026 proposed an estimated $5.5 billion resolution of remaining ovarian talc claims.

Acquisitions

BBVA

  • Turkiye Garanti Bankasi tender offer (Turkey)2022Undisclosed
  • Catalunya Banc (Spain)2014Undisclosed
  • Turkiye Garanti Bankasi 24.9 percent stake (Turkey)2010$5.8B
  • Compass Bancshares (United States)2007$9.6B
  • BBVA Bancomer minority shares (Mexico)2004$4.1B
  • Grupo Financiero Bancomer (Mexico)2000$1.4B
All BBVA acquisitions

Johnson & Johnson

  • Intra-Cellular Therapies2025$14.6B
  • Shockwave Medical2024$13.1B
  • Kenvue separation2023Undisclosed
  • Abiomed2022$16.6B
  • Actelion2017$30B
All Johnson & Johnson acquisitions

Questions about BBVA vs Johnson & Johnson

Who is the CEO of Banco Bilbao Vizcaya Argentaria, S.A. and Johnson & Johnson?

Banco Bilbao Vizcaya Argentaria, S.A. is led by Onur Genç and Johnson & Johnson is led by Joaquin Duato. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was Banco Bilbao Vizcaya Argentaria, S.A. founded vs Johnson & Johnson?

Banco Bilbao Vizcaya Argentaria, S.A. was founded in 1857 — 29 years before Johnson & Johnson, which was founded in 1886. Banco Bilbao Vizcaya Argentaria, S.A.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Johnson & Johnson.

How many employees does Banco Bilbao Vizcaya Argentaria, S.A. have compared to Johnson & Johnson?

Banco Bilbao Vizcaya Argentaria, S.A. employs approximately 127,174 people, while Johnson & Johnson employs approximately 140,800. Johnson & Johnson has the larger workforce at 140,800 employees, compared to Banco Bilbao Vizcaya Argentaria, S.A.'s 127,174. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are Banco Bilbao Vizcaya Argentaria, S.A. and Johnson & Johnson headquartered?

Banco Bilbao Vizcaya Argentaria, S.A. is headquartered in Spain and Johnson & Johnson is headquartered in United States. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.

Who founded Banco Bilbao Vizcaya Argentaria, S.A. and Johnson & Johnson?

Banco Bilbao Vizcaya Argentaria, S.A. was founded by Bilbao Board of Trade. Johnson & Johnson was founded by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson.

Which company has a longer operating history — Banco Bilbao Vizcaya Argentaria, S.A. or Johnson & Johnson?

Banco Bilbao Vizcaya Argentaria, S.A. has been operating for approximately 169 years, making it the more established of the two companies. Johnson & Johnson has been in operation for around 140 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the BBVA vs Johnson & Johnson overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.